These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 33383528)

  • 1. Identification and computational analysis of mutations in SARS-CoV-2.
    Dey T; Chatterjee S; Manna S; Nandy A; Basak SC
    Comput Biol Med; 2021 Feb; 129():104166. PubMed ID: 33383528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Generalized Peptide Regions for Designing Vaccine Effective for All Significant Mutated Strains of SARS-CoV-2.
    Biswas S; Manna S; Dey T; Chatterjee S; Dey S
    Comb Chem High Throughput Screen; 2022; 25(3):414-428. PubMed ID: 34077341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2).
    Sarkar B; Ullah MA; Johora FT; Taniya MA; Araf Y
    Immunobiology; 2020 May; 225(3):151955. PubMed ID: 32517882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrated approach to determine the abundance, mutation rate and phylogeny of the SARS-CoV-2 genome.
    Desai S; Rashmi S; Rane A; Dharavath B; Sawant A; Dutt A
    Brief Bioinform; 2021 Mar; 22(2):1065-1075. PubMed ID: 33479725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2 leading to universal blueprints for vaccine designs.
    Malone B; Simovski B; Moliné C; Cheng J; Gheorghe M; Fontenelle H; Vardaxis I; Tennøe S; Malmberg JA; Stratford R; Clancy T
    Sci Rep; 2020 Dec; 10(1):22375. PubMed ID: 33361777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations on COVID-19 diagnostic targets.
    Wang R; Hozumi Y; Yin C; Wei GW
    Genomics; 2020 Nov; 112(6):5204-5213. PubMed ID: 32966857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomness for Nucleotide Sequences of SARS-CoV-2 and Its Related Subfamilies.
    Chen RM
    Comput Math Methods Med; 2020; 2020():8819942. PubMed ID: 33273962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight.
    Khan MI; Khan ZA; Baig MH; Ahmad I; Farouk AE; Song YG; Dong JJ
    PLoS One; 2020; 15(9):e0238344. PubMed ID: 32881907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets.
    Oliveira SC; de Magalhães MTQ; Homan EJ
    Front Immunol; 2020; 11():587615. PubMed ID: 33193414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scrutinizing the SARS-CoV-2 protein information for designing an effective vaccine encompassing both the T-cell and B-cell epitopes.
    Jain N; Shankar U; Majee P; Kumar A
    Infect Genet Evol; 2021 Jan; 87():104648. PubMed ID: 33264668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CL
    Chitranshi N; Gupta VK; Rajput R; Godinez A; Pushpitha K; Shen T; Mirzaei M; You Y; Basavarajappa D; Gupta V; Graham SL
    J Transl Med; 2020 Jul; 18(1):278. PubMed ID: 32646487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-Cov-2 ORF3a: Mutability and function.
    Bianchi M; Borsetti A; Ciccozzi M; Pascarella S
    Int J Biol Macromol; 2021 Feb; 170():820-826. PubMed ID: 33359807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV infection crosstalk with human host cell noncoding-RNA machinery: An in-silico approach.
    Yousefi H; Poursheikhani A; Bahmanpour Z; Vatanmakanian M; Taheri M; Mashouri L; Alahari SK
    Biomed Pharmacother; 2020 Oct; 130():110548. PubMed ID: 33475497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge.
    Yahalom-Ronen Y; Tamir H; Melamed S; Politi B; Shifman O; Achdout H; Vitner EB; Israeli O; Milrot E; Stein D; Cohen-Gihon I; Lazar S; Gutman H; Glinert I; Cherry L; Vagima Y; Lazar S; Weiss S; Ben-Shmuel A; Avraham R; Puni R; Lupu E; Bar-David E; Sittner A; Erez N; Zichel R; Mamroud E; Mazor O; Levy H; Laskar O; Yitzhaki S; Shapira SC; Zvi A; Beth-Din A; Paran N; Israely T
    Nat Commun; 2020 Dec; 11(1):6402. PubMed ID: 33328475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation.
    Huang SW; Miller SO; Yen CH; Wang SF
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotyping coronavirus SARS-CoV-2: methods and implications.
    Yin C
    Genomics; 2020 Sep; 112(5):3588-3596. PubMed ID: 32353474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
    Froggatt HM; Heaton BE; Heaton NS
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.
    Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X
    Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 basics and vaccine development with a Canadian perspective.
    Liu M; Chen X
    Can J Microbiol; 2021 Feb; 67(2):112-118. PubMed ID: 33136431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoinformatic design of a COVID-19 subunit vaccine using entire structural immunogenic epitopes of SARS-CoV-2.
    Behmard E; Soleymani B; Najafi A; Barzegari E
    Sci Rep; 2020 Nov; 10(1):20864. PubMed ID: 33257716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.